Mechanisms of action of phytochemicals from medicinal herbs in the treatment of Alzheimer's disease

Planta Medica

Volumn 80, Issue 15, 2014, Pages 1249-1258

  Kim, Mi Hye ^a   Kim, Sung Hoon ^a   Yang, Woong Mo ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Alzheimer's disease; drug development; medicinal herbs; phytochemical

Indexed keywords

BERBERINE; CURCUMIN; GINSENOSIDE RG 1; NOOTROPIC AGENT; PUERARIN; SILIBININ; GINSENOSIDE; ISOFLAVONE DERIVATIVE; PLANT MEDICINAL PRODUCT; SILYMARIN;

ALZHEIMER DISEASE; ARTICLE; COGNITION; COPTIS CHINENSIS; CURCUMA LONGA; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; HERB; HUMAN; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; MEMORY CONSOLIDATION; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PANAX NOTOGINSENG; PUERARIA LOBATA; REFERENCE MEMORY; SILYBUM MARIANUM; TRADITIONAL MEDICINE; ANIMAL; CHEMISTRY; COPTIS; CURCUMA; MEDICINAL PLANT; PUERARIA;

ALZHEIMER DISEASE; ANIMALS; BERBERINE; COPTIS; CURCUMA; CURCUMIN; GINSENOSIDES; HUMANS; ISOFLAVONES; MILK THISTLE; PANAX NOTOGINSENG; PHYTOCHEMICALS; PLANTS, MEDICINAL; PUERARIA; SILYMARIN;

EID: 84912567823     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0034-1383038     Document Type: Article

References (85)

1. Burns A., Zaudig M. Mild cognitive impairment in older people. Lancet: 2002; 360 1963 1965
2. Novakovic D., Feligioni M., Scaccianoce S., Caruso A., Piccinin S., Schepisi C., Errico F., Mercuri N. B., Nicoletti F., Nistico R. Profile of gantenerumab and its potential in the treatment of Alzheimer's disease. Drug Des Devel Ther: 2013; 7 1359 1364
3. Yan H., Li L., Tang X. C. Treating senile dementia with traditional Chinese medicine. Clin Interv Aging: 2007; 2 201 208
4. Sinha S., Anderson J. P., Barbour R., Basi G. S., Caccavello R., Davis D., Doan M., Dovey H. F., Frigon N., Hong J., Jacobson-Croak K., Jewett N., Keim P., Knops J., Lieberburg I., Power M., Tan H., Tatsuno G., Tung J., Schenk D., Seubert P., Suomensaari S. M., Wang S., Walker D., Zhao J., McConlogue L., John V. Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature: 1999; 402 537 540
5. Vassar R., Bennett B. D., Babu-Khan S., Kahn S., Mendiaz E. A., Denis P., Teplow D. B., Ross S., Amarante P., Loeloff R., Luo Y., Fisher S., Fuller J., Edenson S., Lile J., Jarosinski M. A., Biere A. L., Curran E., Burgess T., Louis J. C., Collins F., Treanor J., Rogers G., Citron M. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science: 1999; 286 735 741
6. Yankner B. A., Lu T. Amyloid beta-protein toxicity and the pathogenesis of Alzheimer disease. J Biol Chem: 2009; 284 4755 4759
7. De Strooper B., Vassar R., Golde T. The secretases: enzymes with therapeutic potential in Alzheimer disease. Nat Rev Neurol: 2010; 6 99 107
8. Asai M., Iwata N., Yoshikawa A., Aizaki Y., Ishiura S., Saido T. C., Maruyama K. Berberine alters the processing of Alzheimer's amyloid precursor protein to decrease Abeta secretion. Biochem Biophys Res Commun: 2007; 352 498 502
9. Roychaudhuri R., Yang M., Hoshi M. M., Teplow D. B. Amyloid beta-protein assembly and Alzheimer disease. J Biol Chem: 2009; 284 4749 4753
10. Mrak R. E., Griffin W. S. Glia and their cytokines in progression of neurodegeneration. Neurobiol Aging: 2005; 26 349 354
11. Matsuoka Y., Picciano M., La Francois J., Duff K. Fibrillar beta-amyloid evokes oxidative damage in a transgenic mouse model of Alzheimer's disease. Neuroscience: 2001; 104 609 613
12. Ye J., Zhang Y. Curcumin protects against intracellular amyloid toxicity in rat primary neurons. Int J Clin Exp Med: 2012; 5 44 49
13. Doggui S., Belkacemi A., Paka G. D., Perrotte M., Pi R., Ramassamy C. Curcumin protects neuronal-like cells against acrolein by restoring Akt and redox signaling pathways. Mol Nutr Food Res: 2013; 57 1660 1670
14. Chishti M. A., Yang D. S., Janus C., Phinney A. L., Horne P., Pearson J., Strome R., Zuker N., Loukides J., French J., Turner S., Lozza G., Grilli M., Kunicki S., Morissette C., Paquette J., Gervais F., Bergeron C., Fraser P. E., Carlson G. A., George-Hyslop P. S., Westaway D. Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J Biol Chem: 2001; 276 21562 21570
15. Mucke L., Masliah E., Yu G. Q., Mallory M., Rockenstein E. M., Tatsuno G., Hu K., Kholodenko D., Johnson-Wood K., McConlogue L. High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J Neurosci: 2000; 20 4050 4058
16. Caspersen C., Wang N., Yao J., Sosunov A., Chen X., Lustbader J. W., Xu H. W., Stern D., McKhann G., Yan S. D. Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease. FASEB J: 2005; 19 2040 2041
17. Kmietowicz Z. NICE proposes to withdraw Alzheimer's drugs from NHS. BMJ: 2005; 330 495
18. Flicker L., Grimley Evans G. Piracetam for dementia or cognitive impairment. Cochrane Database Syst Rev: 2001; CD001011
19. Stermitz F. R., Lorenz P., Tawara J. N., Zenewicz L. A., Lewis K. Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5′-methoxyhydnocarpin, a multidrug pump inhibitor. Proc Natl Acad Sci U S A: 2000; 97 1433 1437
20. Kuo C. L., Chi C. W., Liu T. Y. The anti-inflammatory potential of berberine in vitro and in vivo. Cancer Lett: 2004; 203 127 137
21. Sack R. B., Froehlich J. L. Berberine inhibits intestinal secretory response of Vibrio cholerae and Escherichia coli enterotoxins. Infect Immun: 1982; 35 471 475
22. Kim K. W., Ha K. T., Park C. S., Jin U. H., Chang H. W., Lee I. S., Kim C. H. Polygonum cuspidatum, compared with baicalin and berberine, inhibits inducible nitric oxide synthase and cyclooxygenase-2 gene expressions in RAW 264.7 macrophages. Vascul Pharmacol: 2007; 47 99 107
23. Hu J. P., Nishishita K., Sakai E., Yoshida H., Kato Y., Tsukuba T., Okamoto K. Berberine inhibits RANKL-induced osteoclast formation and survival through suppressing the NF-kappaB and Akt pathways. Eur J Pharmacol: 2008; 580 70 79
24. Zhu F., Wu F., Ma Y., Liu G., Li Z., Sun Y., Pei Z. Decrease in the production of beta-amyloid by berberine inhibition of the expression of beta-secretase in HEK293 cells. BMC Neurosci: 2011; 12 125
25. Jia L., Liu J., Song Z., Pan X., Chen L., Cui X., Wang M. Berberine suppresses amyloid-beta-induced inflammatory response in microglia by inhibiting nuclear factor-kappaB and mitogen-activated protein kinase signalling pathways. J Pharm Pharmacol: 2012; 64 1510 1521
26. Xu J., Zhang H., Yang F., Yu J. X. [Intervention effect of berberine on expressions of TNF-alpha and receptor type I in Abeta25-35-induced inflammatory reaction in SH-SY5Y cell lines]. Zhongguo Zhong Yao Za Zhi: 2013; 38 1327 1330
27. Durairajan S. S., Liu L. F., Lu J. H., Chen L. L., Yuan Q., Chung S. K., Huang L., Li X. S., Huang J. D., Li M. Berberine ameliorates beta-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model. Neurobiol Aging: 2012; 33 2903 2919
28. Reinke A. A., Gestwicki J. E. Structure-activity relationships of amyloid beta-aggregation inhibitors based on curcumin: influence of linker length and flexibility. Chem Biol Drug Des: 2007; 70 206 215
29. Huang H. C., Tang D., Xu K., Jiang Z. F. Curcumin attenuates amyloid-beta-induced tau hyperphosphorylation in human neuroblastoma SH-SY5Y cells involving PTEN/Akt/GSK-3beta signaling pathway. J Recept Signal Transduct Res: 2014; 34 26 37
30. Xiong Z., Hongmei Z., Lu S., Yu L. Curcumin mediates presenilin-1 activity to reduce beta-amyloid production in a model of Alzheimer's Disease. Pharmacol Rep: 2011; 63 1101 1108
31. Hoppe J. B., Coradini K., Frozza R. L., Oliveira C. M., Meneghetti A. B., Bernardi A., Pires E. S., Beck R. C., Salbego C. G. Free and nanoencapsulated curcumin suppress beta-amyloid-induced cognitive impairments in rats: involvement of BDNF and Akt/GSK-3beta signaling pathway. Neurobiol Learn Mem: 2013; 106 134 144
32. Chang Y., Huang W. J., Tien L. T., Wang S. J. Ginsenosides Rg1 and Rb1 enhance glutamate release through activation of protein kinase A in rat cerebrocortical nerve terminals (synaptosomes). Eur J Pharmacol: 2008; 578 28 36
33. Wang Y. H., Du G. H. Ginsenoside Rg1 inhibits beta-secretase activity in vitro and protects against Abeta-induced cytotoxicity in PC12 cells. J Asian Nat Prod Res: 2009; 11 604 612
34. Li W., Chu Y., Zhang L., Yin L., Li L. Ginsenoside Rg1 attenuates tau phosphorylation in SK-N-SH induced by Abeta-stimulated THP-1 supernatant and the involvement of p38 pathway activation. Life Sci: 2012; 91 809 815
35. Li W., Chu Y., Zhang L., Yin L., Li L. Ginsenoside Rg1 prevents SK-N-SH neuroblastoma cell apoptosis induced by supernatant from Abeta1-40-stimulated THP-1 monocytes. Brain Res Bull: 2012; 88 501 506
36. Huang T., Fang F., Chen L., Zhu Y., Zhang J., Chen X., Yan S. S. Ginsenoside Rg1 attenuates oligomeric Abeta(1-42)-induced mitochondrial dysfunction. Curr Alzheimer Res: 2012; 9 388 395
37. Wu J. Y., Shen Y. Y., Zhu W. J., Chen M. Y., Wang Z. Q., Liu Y., Zhu D. Y., Lou Y. J. [Ginsenoside Rg1 antagonizes beta-amyloid peptide-induced apoptosis in primarily cultured rat neurons via mitochondrial pathway]. Zhejiang Da Xue Xue Bao Yi Xue Ban: 2012; 41 393 401
38. Gong L., Li S. L., Li H., Zhang L. Ginsenoside Rg1 protects primary cultured rat hippocampal neurons from cell apoptosis induced by beta-amyloid protein. Pharm Biol: 2011; 49 501 507
39. Fang F., Chen X., Huang T., Lue L. F., Luddy J. S., Yan S. S. Multi-faced neuroprotective effects of Ginsenoside Rg1 in an Alzheimer mouse model. Biochim Biophys Acta: 2012; 1822 286 292
40. Qicheng F. Some current study and research approaches relating to the use of plants in the traditional Chinese medicine. J Ethnopharmacol: 1980; 2 57 63
41. Fan L. L., Sun L. H., Li J., Yue X. H., Yu H. X., Wang S. Y. The protective effect of puerarin against myocardial reperfusion injury. Study on cardiac function. Chin Med J (Engl): 1992; 105 11 17
42. Zou Y., Hong B., Fan L., Zhou L., Liu Y., Wu Q., Zhang X., Dong M. Protective effect of puerarin against beta-amyloid-induced oxidative stress in neuronal cultures from rat hippocampus: involvement of the GSK-3beta/Nrf2 signaling pathway. Free Radic Res: 2013; 47 55 63
43. Lin F., Xie B., Cai F., Wu G. Protective effect of Puerarin on beta-amyloid-induced neurotoxicity in rat hippocampal neurons. Arzneimittelforschung: 2012; 62 187 193
44. Zhang H. Y., Liu Y. H., Wang H. Q., Xu J. H., Hu H. T. Puerarin protects PC12 cells against beta-amyloid-induced cell injury. Cell Biol Int: 2008; 32 1230 1237
45. Zhang H., Liu Y., Lao M., Ma Z., Yi X. Puerarin protects Alzheimer's disease neuronal cybrids from oxidant-stress induced apoptosis by inhibiting pro-death signaling pathways. Exp Gerontol: 2011; 46 30 37
46. Li J., Wang G., Liu J., Zhou L., Dong M., Wang R., Li X., Li X., Lin C., Niu Y. Puerarin attenuates amyloid-beta-induced cognitive impairment through suppression of apoptosis in rat hippocampus in vivo. Eur J Pharmacol: 2010; 649 195 201
47. Gazak R., Walterova D., Kren V. Silybin and silymarin-new and emerging applications in medicine. Curr Med Chem: 2007; 14 315 338
48. Youn C. K., Park S. J., Lee M. Y., Cha M. J., Kim O. H., You H. J., Chang I. Y., Yoon S. P., Jeon Y. J. Silibinin inhibits LPS-induced macrophage activation by blocking p38 MAPK in RAW 264.7 cells. Biomol Ther (Seoul): 2013; 21 258 263
49. Trouillas P., Marsal P., Svobodova A., Vostalova J., Gazak R., Hrbac J., Sedmera P., Kren V., Lazzaroni R., Duroux J. L., Walterova D. Mechanism of the antioxidant action of silybin and 2, 3-dehydrosilybin flavonolignans: a joint experimental and theoretical study. J Phys Chem A: 2008; 112 1054 1063
50. Yin F., Liu J., Ji X., Wang Y., Zidichouski J., Zhang J. Silibinin: a novel inhibitor of Abeta aggregation. Neurochem Int: 2011; 58 399 403
51. Lu P., Mamiya T., Lu L. L., Mouri A., Zou L., Nagai T., Hiramatsu M., Ikejima T., Nabeshima T. Silibinin prevents amyloid beta peptide-induced memory impairment and oxidative stress in mice. Br J Pharmacol: 2009; 157 1270 1277
52. Lu P., Mamiya T., Lu L. L., Mouri A., Niwa M., Hiramatsu M., Zou L. B., Nagai T., Ikejima T., Nabeshima T. Silibinin attenuates amyloid beta(25-35) peptide-induced memory impairments: implication of inducible nitric-oxide synthase and tumor necrosis factor-alpha in mice. J Pharmacol Exp Ther: 2009; 331 319 326
53. Fassbender K., Simons M., Bergmann C., Stroick M., Lutjohann D., Keller P., Runz H., Kuhl S., Bertsch T., von Bergmann K., Hennerici M., Beyreuther K., Hartmann T. Simvastatin strongly reduces levels of Alzheimer's disease beta-amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proc Natl Acad Sci U S A: 2001; 98 5856 5861
54. Xiu J., Nordberg A., Qi X., Guan Z. Z. Influence of cholesterol and lovastatin on alpha-form of secreted amyloid precursor protein and expression of alpha7 nicotinic receptor on astrocytes. Neurochem Int: 2006; 49 459 465
55. Famer D., Crisby M. Rosuvastatin reduces caspase-3 activity and up-regulates alpha-secretase in human neuroblastoma SH-SY5Y cells exposed to A beta. Neurosci Lett: 2004; 371 209 214
56. Nawrot B. Targeting BACE with small inhibitory nucleic acids - a future for Alzheimer's disease therapy? Acta Biochim Pol: 2004; 51 431 444
57. Frame S., Cohen P. GSK3 takes centre stage more than 20 years after its discovery. Biochem J: 2001; 359 1 16
58. Chang K. A., Kim H. S., Ha T. Y., Ha J. W., Shin K. Y., Jeong Y. H., Lee J. P., Park C. H., Kim S., Baik T. K., Suh Y. H. Phosphorylation of amyloid precursor protein (APP) at Thr668 regulates the nuclear translocation of the APP intracellular domain and induces neurodegeneration. Mol Cell Biol: 2006; 26 4327 4338
59. Judge M., Hornbeck L., Potter H., Padmanabhan J. Mitosis-specific phosphorylation of amyloid precursor protein at threonine 668 leads to its altered processing and association with centrosomes. Mol Neurodegener: 2011; 6 80
60. Martin D., Salinas M., Lopez-Valdaliso R., Serrano E., Recuero M., Cuadrado A. Effect of the Alzheimer amyloid fragment Abeta(25-35) on Akt/PKB kinase and survival of PC12 cells. J Neurochem: 2001; 78 1000 1008
61. Phiel C. J., Wilson C. A., Lee V. M., Klein P. S. GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides. Nature: 2003; 423 435 439
62. Jaworski T., Dewachter I., Lechat B., Gees M., Kremer A., Demedts D., Borghgraef P., Devijver H., Kugler S., Patel S., Woodgett J. R., Van Leuven F. GSK-3alpha/beta kinases and amyloid production in vivo. Nature: 2011; 480 E4 5 discussion E6
63. Nimmerjahn A., Kirchhoff F., Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science: 2005; 308 1314 1318
64. McGeer E. G., McGeer P. L. Inflammatory processes in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry: 2003; 27 741 749
65. Sasaki Y., Ohsawa K., Kanazawa H., Kohsaka S., Imai Y. Iba1 is an actin-cross-linking protein in macrophages/microglia. Biochem Biophys Res Commun: 2001; 286 292 297
66. Bhat R. V., DiRocco R., Marcy V. R., Flood D. G., Zhu Y., Dobrzanski P., Siman R., Scott R., Contreras P. C., Miller M. Increased expression of IL-1beta converting enzyme in hippocampus after ischemia: selective localization in microglia. J Neurosci: 1996; 16 4146 4154
67. McGeer P. L., McGeer E. G. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Brain Res Rev: 1995; 21 195 218
68. Banati R. B., Gehrmann J., Schubert P., Kreutzberg G. W. Cytotoxicity of microglia. Glia: 1993; 7 111 118
69. Hull M., Strauss S., Berger M., Volk B., Bauer J. The participation of interleukin-6, a stress-inducible cytokine, in the pathogenesis of Alzheimer's disease. Behav Brain Res: 1996; 78 37 41
70. Peterson P. K., Hu S., Salak-Johnson J., Molitor T. W., Chao C. C. Differential production of and migratory response to beta chemokines by human microglia and astrocytes. J Infect Dis: 1997; 175 478 481
71. Kelder W., McArthur J. C., Nance-Sproson T., McClernon D., Griffin D. E. Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia. Ann Neurol: 1998; 44 831 835
72. Ito S., Sawada M., Haneda M., Ishida Y., Isobe K. Amyloid-beta peptides induce several chemokine mRNA expressions in the primary microglia and Ra2 cell line via the PI3K/Akt and/or ERK pathway. Neurosci Res: 2006; 56 294 299
73. Bi W., Zhu L., Wang C., Liang Y., Liu J., Shi Q., Tao E. Rifampicin inhibits microglial inflammation and improves neuron survival against inflammation. Brain Res: 2011; 1395 12 20
74. Pan X. D., Chen X. C., Zhu Y. G., Chen L. M., Zhang J., Huang T. W., Ye Q. Y., Huang H. P. Tripchlorolide protects neuronal cells from microglia-mediated beta-amyloid neurotoxicity through inhibiting NF-kappaB and JNK signaling. Glia: 2009; 57 1227 1238
75. Maezawa I., Zimin P. I., Wulff H., Jin L. W. Amyloid-beta protein oligomer at low nanomolar concentrations activates microglia and induces microglial neurotoxicity. J Biol Chem: 2011; 286 3693 3706
76. Zhou Y., Ling E. A., Dheen S. T. Dexamethasone suppresses monocyte chemoattractant protein-1 production via mitogen activated protein kinase phosphatase-1 dependent inhibition of Jun N-terminal kinase and p38 mitogen-activated protein kinase in activated rat microglia. J Neurochem: 2007; 102 667 678
77. Du C., Hu R., Csernansky C. A., Hsu C. Y., Choi D. W. Very delayed infarction after mild focal cerebral ischemia: a role for apoptosis? J Cereb Blood Flow Metab: 1996; 16 195 201
78. Yang J., Liu X., Bhalla K., Kim C. N., Ibrado A. M., Cai J., Peng T. I., Jones D. P., Wang X. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science: 1997; 275 1129 1132
79. Kluck R. M., Bossy-Wetzel E., Green D. R., Newmeyer D. D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science: 1997; 275 1132 1136
80. Li M. H., Jang J. H., Sun B., Surh Y. J. Protective effects of oligomers of grape seed polyphenols against beta-amyloid-induced oxidative cell death. Ann N Y Acad Sci: 2004; 1030 317 329
81. Aksenov M. Y., Markesbery W. R. Changes in thiol content and expression of glutathione redox system genes in the hippocampus and cerebellum in Alzheimer's disease. Neurosci Lett: 2001; 302 141 145
82. Dang T. N., Arseneault M., Zarkovic N., Waeg G., Ramassamy C. Molecular regulations induced by acrolein in neuroblastoma SK-N-SH cells: relevance to Alzheimer's disease. J Alzheimers Dis: 2010; 21 1197 1216
83. Masliah E., Mallory M., Alford M., DeTeresa R., Hansen L. A., McKeel D. W. jr., Morris J. C. Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease. Neurology: 2001; 56 127 129
84. Schulte-Herbruggen O., Braun A., Rochlitzer S., Jockers-Scherubl M. C., Hellweg R. Neurotrophic factors-a tool for therapeutic strategies in neurological, neuropsychiatric and neuroimmunological diseases? Curr Med Chem: 2007; 14 2318 2329
85. Gincel D., Shoshan-Barmatz V. The synaptic vesicle protein synaptophysin: purification and characterization of its channel activity. Biophys J: 2002; 83 3223 3229